TRDA

Conviction 28HealthcareScan · Thu, Jun 25, 2026

TRDA$7.12-5.64%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 245.47K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Entrada Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.entradatx.com ↗

Price7.12

Change-5.64%

Gap-0.13%

Rel volume1.77×

Avg volume253.88K

Avg $ vol1.71M

SMA 206.74

SMA 508.95

SMA 2009.48

Price vs 50-20.52%

Price vs 200-24.95%

MA stackbearish

50/200 crossdeath · 3d

Supertrenddown · 7.93

RSI (14)47

MACD hist0.28

MACD cross—

Stoch %K / %D71 / 85

ADX (14)21

+DI / −DI21 / 20

RSI divergence—

MACD divergence—

ATR %+8.39%

ADR %6.98%

52w high16.03

52w low5.02

From 52w high-55.61%

Above 52w low+41.73%

New 52w highNo

SqueezeOff

Bollinger width22.84%

%B0.75

Donchian pos71.13%

Donchian high7.67

Donchian low5.76

AVWAP (52w high)6.95

vs AVWAP high+2.41%

AVWAP (52w low)8.52

vs AVWAP low-16.50%

OBV trendFlat

Chaikin MF (20)0.05

Today vs 20d1.77×

Avg vol (14d)245.47K

Avg vol (20d)253.88K

Avg $ vol (20d)1.71M

Market cap276.21M

RS 3m (vs SPY)-46.52%

RS 6m (vs SPY)-39.07%

RS line new highNo

Trend template3/8

Technical rank26.9

1 week+4.48%

1 month+6.19%

3 months-40.95%

6 months-33.00%

1 year+0.49%

YTD-29.20%

P/E-1.92

P/B1.02

P/S10.87

P/FCF-2.13

EPS-3.47

Div yield—

ROE-53.07%

ROA-42.84%

Debt/Eq—

Current13.90

EV/EBITDA—

Gross margin—

Net margin-565.48%

Rev growth-87.94%

EPS growth-319.04%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value199.76M

Revenue875K

Net income-39.72M

Gross profit—

Free cash flow-129.55M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out38.82M

Employees152

ListedFri, Oct 29, 2021

Free float23.95M

Float %62.7%

Short interest1.73M

Days to cover4.5d

Short volume54.5%

Squeeze score58 / 100

Next earningsWed, Aug 5, 2026 (41d)

EPS forecast−$1.16 · 4 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction28 / 100

Pattern quality—

Tech rank26.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.99

Support5.68

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TRDA

All disclosures →

No recent disclosed trades by Congress in TRDA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TRDA · 2 buys · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Zeiher Bernhardt G Director · Common Stock · 2026-05-20	Buy	5K	$29K	2026-05-20	2026-05-21
Dowden Nathan J President & COO · Common Stock · 2026-05-04	Exercise	15K	$26K	2026-05-04	2026-05-04
Sethuraman Natarajan President, Research & Develop. · Common Stock · 2026-05-04	Sell	25.91K	$399K	2026-05-04	2026-05-04
Dowden Nathan J President & COO · Common Stock · 2026-05-04	Sell	15K	$230K	2026-05-04	2026-05-04
Dowden Nathan J President & COO · Stock Option (Right to Buy) · 2026-05-04	Exercise	15K	$0	2026-05-04	2026-05-04

SEC filings

EDGAR filings in TRDA · 1 recent

EDGAR →

8-K8-KWed, Jun 10, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.